Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P000054/S076

INFUSE Bone Graft

MEDTRONIC SOFAMOR DANEK USA, INC. · Decision date Feb 24, 2026

FDA DECISIONP000054/S076

What did the FDA decide?

FDA records P000054/S076 as a supplement to PMA P000054, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 24, 2026.

FDA approval order statement

Change to upgrade the EO Sterilization Chamber Control System at the contract sterilization site from the Antares Chamber Control System to the Konnexis AccuSOLO Chamber Control System
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Feb 24, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P000054/S076
Regulatory pathway
PMA supplement
Product code
MPW
Decision code
OK30
Decision date
Feb 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction.

Product code
MPW
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P000054/S076 received

    Application receipt date recorded by FDA.

  2. P000054/S076 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P000054. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P000054

Product / regulatory recordCompanyPathwayDecision dateSource
INFUSE Bone GraftP000054/S077
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementMar 19, 2026FDA
Infuse Bone GraftP000054/S078
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementJul 28, 2026FDA
INFUSE BONE GRAFTP000054/S075
MEDTRONIC SOFAMOR DANEK USA, INC.PMA supplementAug 26, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Sofamor DANEK USA, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
1800 Pyramid Pl., Memphis, TN, 38132

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records